E-Mycin™
Active ingredients: erythromycin ethylsuccinate
Consumer medicine information
Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
Erythromycin is indicated for the treatment of the following infections:,Streptococcus pyogenes (group A B-haemolytic Streptococcus) Upper and lower respiratory tract, skin and skin structure infections of mild to moderate severity. When oral medication is given, patient must comply with the prescribed regimen. Therapeutic dose should be administered for at least 10 days.,a-haemolytic Streptococci (viridans group) No controlled clinical efficacy trials have been conducted, however oral erythromycin has been suggested by the American Heart Association and the American Dental Association for use in bacterial endocarditis prophylaxis prior to dental/surgical procedures of the upper respiratory tract in penicillin-hypersensitive patients with a history of rheumatic, congenital or other acquired valvular heart disease. Erythromycin is not suitable prior to genitourinary or gastrointestinal tract surgery.,Staphylococcus aureus Acute infections of skin and skin structure of mild to moderate severity. Bacterial resistance may emerge during treatment hence cultures and sensitivity tests should be performed.,Streptococcus pneumoniae (Diplococcus pneumoniae) Upper (e.g. otitis media, pharyngitis) and lower respiratory tract infections (e.g. pneumonia) of mild to moderate degree.,Mycoplasma pneumoniae (Eaton agent, PPLO) For respiratory infections due to this organism.,Haemophilus influenzae For upper respiratory tract infections of mild to moderate severity. Not all strains of this organism are susceptible at the erythromycin concentrations normally achieved.,Chlamydia trachomatis and Ureaplasma urealyticum These organisms are sensitive to erythromycin; clinical studies have demonstrated erythromycin's efficacy in nongonococcal urethritis due to these organisms. A minimum of 10 days therapy is required.,Chlamydia trachomatis infection (excluding non-gonococcal urethritis) Erythromycin has shown to be effective in treating trachoma or inclusion body conjunctivitis, acute inclusion conjunctivitis of the newborn (inclusion blennorrhoea) and pneumonia in infants caused by Chlamydia trachomatis.,Treponema pallidum Erythromycin is an alternate choice of treatment for primary syphilis in patients allergic to penicillins. Spinal fluid examinations should be done before treatment and as part of follow-up post therapy.,Neisseria gonorrhoeae Erythromycin lactobionate for injection in conjunction with oral erythromycin ethyl succinate, as an alternative treatment for acute uncomplicated gonorrhoea in female patients with penicillin hypersensitivity. Before treatment, patients who are suspected of also having syphilis should be evaluated including a microscopic examination for T. pallidum (by immunofluorescence or darkfield) before receiving erythromycin, and monthly serologic tests should be performed for a minimum of 4 months.,Corynebacterium diphtheriae, C. minutissimum and C. (propionibacterium) acnes As an adjunct to diphtheria antitoxin, to prevent establishment of carriers, and to eradicate the organism in carriers; in the treatment of erythrasma; adjunctive therapy of moderate to severe acne.,Bordetella pertussis For early elimination of the causative organism from the nasopharynx. Therapeutic doses should be continued for at least 10 days. The clinical course of the disease is not altered.,Clostridium tetani In vitro, Clostridium tetani is sensitive to erythromycin. Erythromycin may be used prophylactically in penicillinhypersensitive persons for 5 days. As the value of antibiotic prophylaxis in tetanus is not unequivocally established, wounds should be regularly examined.,Legionnaires' disease Although no controlled clinical efficacy studies have been conducted, in vitro and limited preliminary clinical data suggest that erythromycin may be effective in treating Legionnaires' disease.,Campylobacter fetus (subspecies) jejuni, Listeria monocytogenes Infections due to these organisms when antibiotic therapy is indicated.
Source: ARTG
Storage conditions
- Shelf lifetime is 18 Months
- Store below 25 degrees Celsius
Source: ARTG
How to use this medicine
Non-composite pack
This medicine contains one component only.
Component
- Oral Liquid, powder for
- Oral
- Pink free flowing granules. When reconstituted, pink suspension with cherry odour and flavour.
Source: ARTG
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
- 1 x 100mL
Source: ARTG
Is this medicine subsidised?
This medicine was verified as available on the Pharmaceutical Benefits Scheme (PBS) on 1 August 2026, under PBS item codes 3334L (Opens in new tab) and 2424N (Opens in new tab). Ask your pharmacist or doctor about your eligibility
Source: PBS
Pregnant or planning a pregnancy?
For the active ingredient: erythromycin ethylsuccinate
You should seek advice from your doctor or pharmacist before taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Source: AHT
Reporting side effects
If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).
You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)
Source: ARTG
Data sources
- Australian Health Thesaurus (AHT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Medicines Terminology (AMT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Register of Therapeutic Goods (ARTG) (Opens in new tab) – Last updated on 3 August 2026
- Pharmaceutical Benefits Scheme (PBS) (Opens in new tab) – Last updated on 3 August 2026
- Medicines Information Pty Ltd (Opens in new tab) – Last updated on 4 March 2026
Disclaimer
Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).
Symptom Checker
Worried about your health?
Select a symptom, answer some questions, get advice